SOURCE: Wolters Kluwer

WOLTERS KLUWER

August 18, 2016 06:00 ET

Wolters Kluwer Announces Sentri7 Capabilities for Direct CDA Automation of NHSN Reporting

MADISON, WI--(Marketwired - Aug 18, 2016) - The Health division of Wolters Kluwer (AEX: WKL), a leading global provider of information and point of care solutions for the healthcare industry, announced today the release of updates to its Sentri7® electronic surveillance solution. The most significant is new technology for Direct Clinical Document Architecture (CDA) Automation of reporting to the Centers for Disease Control and Prevention's (CDC) National Healthcare Safety Network (NHSN).

With the new Direct CDA Automation, Sentri7 users can now send all reporting documents to NHSN directly from within Sentri7 with just one click. This capability eliminates manual log-in and upload of documents to the NHSN portal, greatly improves efficiency, and reduces possibility of clerical error in submitting reports.

"The ability to send reports directly to NHSN through Sentri7 is a great time saver! With one click, I can send all of my reports straight to NHSN," said Angela Loving, Infection Prevention Coordinator with a nationally recognized women's hospital. "It has reduced the time I need to spend reporting to NHSN and frees up time to focus on other infection prevention responsibilities."

"Sentri7 is committed to streamlining the workflow of infection preventionists to maximize their time preventing infections and minimize time spent on documenting and reporting events to NHSN," said Karen Kobelski, Vice President and General Manager for Pharmacy OneSource at Wolters Kluwer. "The addition of Direct CDA Automation can help infection preventionists allocate more time to preventing these critical infections."

Sentri7 is a web-based, real-time, decision support application that drives continuous improvement and empowers healthcare organizations to achieve excellence in care delivery. It supports multiple infection prevention responsibilities, including investigation of HAIs, isolation management, multi-drug resistant organism (MDRO) management and compliance with federal and state reporting requirements.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2015 annual revenues of EUR 4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

Contact Information